About the Epidemiology and Genomics Research Program
The National Cancer Institute's (NCI) Epidemiology and Genomics Research Program (EGRP), in the Division of Cancer Control and Population Sciences (DCCPS), funds research in human populations to understand the causes of cancer and related outcomes. The Program fosters interdisciplinary collaborations and the development and use of resources and technologies to advance cancer research and its translation to serve as the basis for clinical and public health interventions.
To reduce the cancer burden in human populations by identifying determinants of cancer risks and improving outcomes.
EGRP consists of the Office of the Associate Director and four Branches, described below. View the staff list.
The Office of the Associate Director (OAD) develops and implements the mission and scientific and strategic agenda of the Program which aims to increase our understanding of the determinants of cancer and cancer-related outcomes in human populations.
The Clinical and Translational Epidemiology Branch (CTEB) focuses on etiologic and genomic factors that influence cancer progression, recurrence, survival, and other treatment outcomes, and factors associated with cancer development among individuals with underlying diseases and conditions.
The Host Susceptibility Factors Branch (HSFB) focuses on factors that influence personal susceptibility to cancer in humans, such as genetic, epigenetic, immunological, hormonal, and biological pathways; and social, cultural, racial, and ethnic factors.
The Methods and Technologies Branch (MTB) focuses on methods for epidemiologic data collection, study design and analysis, and development and adaptation of laboratory and technical approaches for large studies in human populations.